Thompson Travis Alvin

CHIEF ACCOUNTING OFFICERBICYCLE THERAPEUTICS PLC (BCYC) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026Sell(S)1K$6.45$7K66K
Jan 2, 2026Sell(S)1K$6.80$9K67K
Jan 2, 2026Grant(A)38K$069K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Grant(A)75K$075K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001983944-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: